{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:26:10Z","timestamp":1780622770398,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Orthopaedic Science"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s00776-011-0106-7","type":"journal-article","created":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T02:17:31Z","timestamp":1308536251000},"page":"458-466","source":"Crossref","is-referenced-by-count":12,"title":["Insights on PRAME and osteosarcoma by means of gene expression profiling"],"prefix":"10.1016","volume":"16","author":[{"given":"Silvia Regina Caminada","family":"Toledo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indhira Dias","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine Tesser","family":"Gamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane A.","family":"Dalla Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Tereza Seixas","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reynaldo J.","family":"Garcia-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Sergio","family":"Petrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Antonio","family":"Zago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Proto-Siqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson A.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oswaldo K.","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Severino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Z.N.","family":"Vencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Moreira-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.G.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s00776-011-0106-7_bb0010","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1699-0463.1998.tb00210.x","article-title":"Melanoma-associated antigens recognized by cytotoxic T lymphocytes","volume":"106","author":"Kirkin","year":"1998","journal-title":"Apmis."},{"key":"10.1007\/s00776-011-0106-7_bb0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1034\/j.1600-065X.2002.18803.x","article-title":"Cancer\/testis antigens: an expanding family of targets for cancer immunotherapy","volume":"188","author":"Scanlan","year":"2002","journal-title":"Immunol Rev."},{"key":"10.1007\/s00776-011-0106-7_bb0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)80426-4","article-title":"Caracterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor","volume":"6","author":"Ikeda","year":"1997","journal-title":"Immunity."},{"key":"10.1007\/s00776-011-0106-7_bb0025","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1046\/j.1365-2141.1998.00982.x","article-title":"PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukemia cells","volume":"102","author":"van Baren","year":"1998","journal-title":"Br J Haematol."},{"issue":"2","key":"10.1007\/s00776-011-0106-7_bb0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000133810","article-title":"Localization of the MAGE1 gene encoding a human melanoma antigen to chromosome Xq28","volume":"67","author":"Wang","year":"1994","journal-title":"Cytogenet Cell Genet."},{"issue":"8","key":"10.1007\/s00776-011-0106-7_bb0035","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrc1669","article-title":"Cancer\/testis antigens, gametogenesis and cancer","volume":"5","author":"Simpson","year":"2005","journal-title":"Nat Rev Cancer."},{"key":"10.1007\/s00776-011-0106-7_bb0040","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2005.07.003","article-title":"The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling","volume":"122","author":"Epping","year":"2005","journal-title":"Cell."},{"issue":"22","key":"10.1007\/s00776-011-0106-7_bb0045","doi-asserted-by":"crossref","first-page":"10639","DOI":"10.1158\/0008-5472.CAN-06-2522","article-title":"A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer","volume":"66","author":"Epping","year":"2006","journal-title":"Cancer Res."},{"key":"10.1007\/s00776-011-0106-7_bb0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/35106036","article-title":"The promise of retinoids to fight against cancer","volume":"1","author":"Altucci","year":"2001","journal-title":"Nat Rev Cancer."},{"key":"10.1007\/s00776-011-0106-7_bb0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ijc.22118","article-title":"Cancer-germline gene expression in pediatric solid tumors using quantitative real-time PCR","volume":"120","author":"Jacobs","year":"2006","journal-title":"Int J Cancer."},{"key":"10.1007\/s00776-011-0106-7_bb0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11060-008-9577-6","article-title":"Selective cancer-germline gene expression in pediatric brain tumors","volume":"88","author":"Jacobs","year":"2008","journal-title":"J Neurooncol."},{"key":"10.1007\/s00776-011-0106-7_bb0065","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0031-3955(05)70540-X","article-title":"Osteosarcoma","volume":"44","author":"Meyers","year":"1997","journal-title":"Pediatr Clin North Am."},{"issue":"20","key":"10.1007\/s00776-011-0106-7_bb0070","first-page":"776","article-title":"Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of patients treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols","volume":"2002","author":"Bielack","year":"1702","journal-title":"J Clin Oncol."},{"key":"10.1007\/s00776-011-0106-7_bb0075","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1002\/cncr.11456","article-title":"Neoadjvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor","volume":"97","author":"Bacci","year":"2003","journal-title":"Cancer"},{"key":"10.1007\/s00776-011-0106-7_bb0080","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1200\/JCO.2005.03.5352","article-title":"Brazilian Osteosarcoma Treatment Group Studies III and IV. Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival","volume":"24","author":"Petrilli","year":"2006","journal-title":"J Clin Oncol."},{"key":"10.1007\/s00776-011-0106-7_bb0085","first-page":"549","article-title":"Osteosarcoma: clinical practice and the expanding role of biology","volume":"2","author":"Gorlick","year":"2002","journal-title":"J Musculoskel Neuron Interact."},{"issue":"1","key":"10.1007\/s00776-011-0106-7_bb0090","first-page":"138","article-title":"BayBoots: a model-free Bayesian tool to identify class markers from gene expression data","volume":"5","author":"V\u00eancio","year":"2006","journal-title":"Genet Mol Res."},{"key":"10.1007\/s00776-011-0106-7_bb0095","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/35077246","article-title":"Progress in human tumour immunology and immunotherapy","volume":"411","author":"Rosenberg","year":"2001","journal-title":"Nature."},{"key":"10.1007\/s00776-011-0106-7_bb0100","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1128\/MCB.19.11.7327","article-title":"DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter","volume":"19","author":"De Smet","year":"1999","journal-title":"Mol Cell Biol."},{"key":"10.1007\/s00776-011-0106-7_bb0105","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1073\/pnas.93.14.7149","article-title":"The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation","volume":"93","author":"De Smet","year":"1996","journal-title":"Proc Natl Acad Sci USA."},{"issue":"1","key":"10.1007\/s00776-011-0106-7_bb0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/jor.1100150119","article-title":"Expression of MAGE genes in osteosarcoma","volume":"15","author":"Sudo","year":"1997","journal-title":"J Orthop Res."},{"issue":"6","key":"10.1007\/s00776-011-0106-7_bb0115","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.bjc.6600174","article-title":"Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications","volume":"86","author":"Sigalotti","year":"2002","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1007\/s00776-011-0106-7_bb0120","first-page":"443","article-title":"Somatic mutation of the Caspase-5 gene in human lung cancer","volume":"12","author":"Hosomi","year":"2003","journal-title":"Int J Mol Med."},{"issue":"10","key":"10.1007\/s00776-011-0106-7_bb0125","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1038\/sj.bjc.6604725","article-title":"A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators","volume":"99","author":"Maaser","year":"2008","journal-title":"Br J Cancer."},{"issue":"5","key":"10.1007\/s00776-011-0106-7_bb0130","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/eji.200535514","article-title":"Genetic vaccines against Ep-CAM break tolerance to self in a limited subset of subjects: initial identification of predictive biomarkers","volume":"36","author":"Elia","year":"2006","journal-title":"Eur J Immunol."},{"key":"10.1007\/s00776-011-0106-7_bb0135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.bjc.6603494","article-title":"EpCAM (CD326) finding its role in cancer","volume":"96","author":"Bauerle","year":"2007","journal-title":"Br J Cancer."},{"issue":"6","key":"10.1007\/s00776-011-0106-7_bb0140","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.1365-3083.2000.00737.x","article-title":"Interleukin-12 induces efficient lysis of natural killer-sensitive and natural killer-resistant human osteosarcoma cells: the synergistic effect of interleukin-2","volume":"51","author":"Mariani","year":"2000","journal-title":"Scand J Immunol."},{"issue":"10","key":"10.1007\/s00776-011-0106-7_bb0145","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1158\/1078-0432.CCR-07-1992","article-title":"Critical role of notch signaling in osteosarcoma invasion and metastasis","volume":"14","author":"Zhang","year":"2008","journal-title":"Clin Cancer Res."},{"issue":"12","key":"10.1007\/s00776-011-0106-7_bb0150","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/sj.bjc.6605060","article-title":"Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulation","volume":"100","author":"Tanaka","year":"2009","journal-title":"Br J Cancer."},{"issue":"9","key":"10.1007\/s00776-011-0106-7_bb0155","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1091\/mbc.4.9.953","article-title":"The extracellular matrix as a cell survival factor","author":"Meredith","year":"1993","journal-title":"Mol Biol Cell."}],"container-title":["Journal of Orthopaedic Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265815307910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265815307910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00776-011-0106-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T21:36:56Z","timestamp":1560289016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0949265815307910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0949265815307910"],"URL":"https:\/\/doi.org\/10.1007\/s00776-011-0106-7","relation":{},"ISSN":["0949-2658"],"issn-type":[{"value":"0949-2658","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}